Status:
SUSPENDED
Biomarkers for Bipolar Disorder: Chaperones and Reticulum Endoplasmatic Stress Response CHAP´s Study
Lead Sponsor:
University of Sao Paulo
Conditions:
Bipolar Disease Type I
Eligibility:
All Genders
18-55 years
Brief Summary
The purpose of this study is to determine expression of chaperones proteins from the endoplasmatic reticulum stress response system in bipolar I patients (manic phase) compared to healthy controls. H...
Eligibility Criteria
Inclusion
- Bipolar Disease type I manic phase
- YMRS \> 14
- HDRS \< 9
Exclusion
- Use of lithium, divalproate, or carbamazepine in therapeutic levels over the past 30 days
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00994630
Start Date
January 1 2010
Last Update
August 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mood Disorders Program, Institute of Psychiatry, Faculty of Medicine, University of Sao Paulo
São Paulo, São Paulo, Brazil